15:55 24/04/2014 Pfizer, Inc. (PFE) Declares $0.26 Quarterly Dividend; 3.4% Yield
Pfizer, Inc. (PFE) Declares $0.26 Quarterly Dividend; 3.4% Yield
StreetInsider.com (subscription) - 5 hours ago
Preliminary results from the Annual Meeting of Shareholders indicate that the company's 12 directors were re-elected to one-year terms and that shareholders ratified the selection of KPMG LLP as Pfizer's independent registered public accounting firm ...
Pfizer Hosts Annual Meeting of Shareholders Declares 26-Cent Second-Quarter ... - The Wall Street Transcript

10:45 24/04/2014 4 Pharmaceuticals With Significant Potential
4 Pharmaceuticals With Significant Potential
Seeking Alpha - 10 hours ago
Indeed, since Pfizer lost its Lipitor patent, the company has moved quickly to streamline its business, spinning off its nutrition arm to Nestle and doing the same with its animal health department to Zoetis.

17:41 23/04/2014 Pfizer Inc. (NYSE:PFE) Gearing Up For A Mega-Merger With Astra-Zeneca
Pfizer Inc. (NYSE:PFE) Gearing Up For A Mega-Merger With Astra-Zeneca
WallStreetPR - Apr 23, 2014
Boston, MA 04/23/2014 (wallstreetpr) - American pharma giant Pfizer Inc. (NYSE:PFE) has reportedly put in a bid of $100 billion to buy British drug maker, Astra-Zeneca.

15:26 23/04/2014 Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan
Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan
Wall St. Cheat Sheet - Apr 23, 2014
It seems Pfizer Inc.'s (NYSE:PFE) attempts to woo AstraZeneca (NYSE:AZN) have failed, as AstraZeneca has rejected an offer from the world's largest pharmaceutical company, according to a report from The New York Times.
AstraZeneca reports profits fall as predators circle - CNBC.com
AstraZeneca Gains on Takeover Speculation as Profit Drops - Bloomberg

23:30 21/04/2014 Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?
Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?
Motley Fool - Apr 21, 2014
Big-time pharma mergers have had a mixed track record, with large combinations often leading to significant cost reductions (and firings) in sales and administration but at the cost of large disruptions to R&D.
Pfizer, AstraZeneca Are Ripe for Pharma Deal: Real M&A - Bloomberg
Pfizer Looking For Another Mega-Merger – This Time With AstraZeneca - Bidness Etc

22:02 21/04/2014 Pfizer agrees to $190 million settlement over generic Neurontin
Pfizer agrees to $190 million settlement over generic Neurontin
Reuters - Apr 21, 2014
Pfizer, which did not admit to liability or wrongdoing, said in a statement that the settlement "reflects a desire by the company to concentrate on its business and the needs of patients and prescribers, while also reducing the cost and distraction of ...

13:34 21/04/2014 Report: Pfizer Inc. Attempted to Buy AstraZeneca plc (PFE, AZN)
Report: Pfizer Inc. Attempted to Buy AstraZeneca plc (PFE, AZN)
Dividend.com (blog) - Apr 21, 2014
According to an article on Bloomberg on Sunday evening, pharma giant Pfizer (PFE ) was recently in talks to purchase London-based biopharmaceutical company AstraZeneca (AZN ). The negotiations have since ended, and the companies are no longer ...

11:43 21/04/2014 Pfizer, Inc. (PFE) Said to Recently Hold Talks to Acquire AstraZeneca (AZN)
Pfizer, Inc. (PFE) Said to Recently Hold Talks to Acquire AstraZeneca (AZN)
StreetInsider.com (subscription) - Apr 21, 2014
Pfizer (NYSE: PFE) shares are active in early trading Monday following news over the weekend that the company may have been in talks to acquire AstraZeneca (NYSE: AZN).

2:50 21/04/2014 Report: Pfizer approached AstraZeneca about purchase
Report: Pfizer approached AstraZeneca about purchase
The News Journal - Apr 21, 2014
Pfizer Inc. approached AstraZeneca to purchase the company for more than $100 billion, but those talks were largely informal and appear to have ceased for now, according to a Sunday Times of London report citing unnamed “senior investment bankers and ...

16:14 20/04/2014 Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca
Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca
Bloomberg - Apr 20, 2014
Pfizer Inc. (PFE), the world's biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.